Regulation (EC) No 726 of the European Parliament and of the Council of 31 March 2004 establishing a Community procedure for the authorisation of medicinal products which highlights key aspects of pharmaceutical regulation within the European Union. This regulation has become fundamental to the creation of a unified procedure for the authorization of medicines, which is of great importance for both manufacturers and consumers. The author’s team behind this book includes experts in law, pharmaceuticals and public health, which allows a deeper understanding of not only the legal aspects, but also the practical application of the regulation. The book will be of interest to both professionals working in the pharmaceutical industry and students studying law, medicine or pharmaceutics. It can also attract the attention of researchers and analysts dealing with health and regulatory issues in Europe. This book explores key topics such as the process of drug authorization, clinical trial requirements, drug safety and efficacy, and quality control mechanisms. Readers will be able to learn about how regulations affect the availability of drugs on the market, what procedures are necessary to obtain a sales permit, and how this affects the health of the population. Interestingly, the authors not only present the facts, but also analyze the consequences of the implementation of the regulation, which makes the book especially relevant in the light of modern challenges in the field of health care. The style of presentation of the book is clear and logical, which makes it easy to assimilate even the most complex legal terms. The team of authors uses examples from practice, which makes the material more lively and understandable. The book is not overloaded with theory, but offers the reader practical recommendations and advice, which makes it an indispensable tool for anyone who wants to understand the intricacies of European pharmaceutical legislation. If you are interested in health regulation, patient rights or want to understand how the authorization system of medicines in Europe works, this book will be a real find for you. It can be useful for both experienced professionals and beginners seeking to expand their knowledge in this area. In addition, the “Regulation of the European Parliament and of the Council 726/2004” may be of interest to those who study international law and want to understand how national legislations interact with European norms. The book also raises important ethics issues in pharmaceutics, making it relevant for discussion within professional and academic circles. In conclusion, “Regulation of the European Parliament and of the Council 726 /2004” is not just a legal document, but an in-depth analysis of the system that affects the health of millions of people. Reading this book will allow you not only to become familiar with the basics of pharmaceutical regulation, but also to think about the broader social and ethical aspects associated with access to medicines. Do not miss the opportunity to expand your horizons and get valuable information that can have an impact on your professional activities or research work.